QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC
Yaqi Li(Nanchang University), Chao Shi(Henan University of Engineering), Zhenyu Zhai(Nanchang University), Jianping Xiong(Nanchang University), Libin Deng(Nanchang University), Hua Liu(China Pharmaceutical University), Mei Liu(Shandong University of Traditional Chinese Medicine), Xue Lv(Nanchang University), Cheng Zhang(Nanchang University)
Cited by 3
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders
|Proceedings of the National Academy of Sciences|2010|854
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix
|Stem Cell Research & Therapy|2017|462